Recombinant hirudin: a new prospect in thrombosis.
Talbot
M
M
Ciba-Geigy Pharmaceuticals, Horsham, West Sussex, UK.
D000818:Animals; D001815:Bloodletting; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D024764:Hirudin Therapy; D006629:Hirudins / Q000031:analogs & derivatives / Q000494:pharmacology; D006801:Humans; D007865:Leeches; D011994:Recombinant Proteins / Q000627:therapeutic use; D013917:Thrombin / Q000037:antagonists & inhibitors; D015912:Thrombolytic Therapy
D005343:Fibrinolytic Agents; D006629:Hirudins; D011994:Recombinant Proteins; D013917:Thrombin; C060225:desirudin